2seventy bio Inc (TSVT)
4.76
-0.17
(-3.45%)
USD |
NASDAQ |
May 03, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
2seventy bio SG&A Expense (Quarterly): 16.20M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.20M |
September 30, 2023 | 13.00M |
June 30, 2023 | 19.49M |
March 31, 2023 | 20.72M |
December 31, 2022 | 18.70M |
September 30, 2022 | 19.61M |
June 30, 2022 | 17.28M |
Date | Value |
---|---|
March 31, 2022 | 23.86M |
December 31, 2021 | 24.48M |
September 30, 2021 | 23.00M |
June 30, 2021 | 21.40M |
March 31, 2021 | 24.63M |
December 31, 2020 | 21.95M |
September 30, 2020 | 22.10M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
13.00M
Minimum
Sep 2023
24.63M
Maximum
Mar 2021
20.46M
Average
21.06M
Median
SG&A Expense (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 2.367B |
Johnson & Johnson | 5.057B |
Macrogenics Inc | 12.56M |
Akebia Therapeutics Inc | 25.44M |
Tango Therapeutics Inc | 9.105M |